Zobrazeno 1 - 10
of 1 259
pro vyhledávání: '"Y Najean"'
Publikováno v:
Scandinavian Journal of Haematology. 22:343-356
A prospective study of 352 patients with aplastic anaemia on androgen therapy has been performed. The following main observations have been obtained: The actuarial mortality rate at the 20th month is 52 %, half the deaths being observed during the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fed30dc0a641ec4bb48a5de72ce1d0c8
https://doi.org/10.1111/j.1600-0609.1979.tb00430.x
https://doi.org/10.1111/j.1600-0609.1979.tb00430.x
Autor:
Y. Najean
Publikováno v:
EMC - Tratado de Medicina. 5:1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad0ae478ff7556bc47297e94ff76b6ac
https://doi.org/10.1016/s1636-5410(01)70147-x
https://doi.org/10.1016/s1636-5410(01)70147-x
Autor:
F. Nivelon, A. Le Duc, C. Borschneck, Y. Najean, C. Role, Olivier Cussenot, M. Chiron, D. Rastel, M.-H. Schlageter, H. Francois, Pierre Teillac, François Desgrandchamps, Toubert Me, J. Guillet, Paul Meria
Publikováno v:
European Journal of Cancer. 32:2088-2093
Prostate-specific antigen (PSA) is a protease able to bind to serum antiproteases as alpha 1 antichymotrypsin (ACT). Free PSA (FPSA) corresponds to the fraction of total PSA (TPSA) which is unbound to ACT. Specific detection of the FPSA seems to be a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4373a961f14c48a867e115d4384b9c8
https://doi.org/10.1016/s0959-8049(96)00245-6
https://doi.org/10.1016/s0959-8049(96)00245-6
Publikováno v:
Clinical Drug Investigation. 10:198-207
This prospective, double-blind, controlled, multicentre trial was carried out to evaluate the efficacy and tolerability of iron protein succinylate (ITF 282) in comparison with iron sulfate in the treatment of iron deficiency anaemia. 174 patients (9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61ba84d7eb41c80111b6f8bc48abe407
https://doi.org/10.2165/00044011-199510040-00002
https://doi.org/10.2165/00044011-199510040-00002
Autor:
Fabien Guidez, I Krawice, A de Gentile, C Dubois, Y. Najean, Pierre Fenaux, Marie-Elisabeth Toubert, Sylvie Castaigne, Nicole Balitrand, Marie-Hélène Schlageter
Publikováno v:
Europe PubMed Central
Acute promyelocytic leukemia (APL) is a homogeneous subgroup of acute myeloid leukemias (AMLs) characterized by the presence of the t(15.17) translocation and the resulting promyelocytic myeloid leukemia/retinoic acid receptor a (PML/RARa) fusion pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ec183ccf11c6ecc4410cfe1ad432bd8
https://doi.org/10.1182/blood.v83.11.3264.bloodjournal83113264
https://doi.org/10.1182/blood.v83.11.3264.bloodjournal83113264
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 8:105-112
Resume Les performances cliniques du CA.549, un nouveau marqueur tumoral dose dans le serum par une methode immunoradiometrique (Irma) en deux etapes commercialisee par Hybritech (HybriBREScan), ont ete analysees pour le diagnostic et le suivi des pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1253431b29672b5f0b6c1b934f5a2e6f
https://doi.org/10.1016/s0923-2532(05)80378-3
https://doi.org/10.1016/s0923-2532(05)80378-3
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 8:248-252
Resume Les cancers de la vessie se classent au deuxieme rang parmi les tumeurs urologiques, apres le cancer de la prostate. Elles posent en particulier le probleme de leur evolutivite, meme au sein des tumeurs superficielles qui peuvent devenir a tou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a03c7039a7264f0ffc312aacd9e1ff61
https://doi.org/10.1016/s0923-2532(05)80009-2
https://doi.org/10.1016/s0923-2532(05)80009-2
Autor:
Y. Najean, O. Haguenauer
Publikováno v:
Blood. 76:2222-2228
In the presence of aplastic anemia (AA), therapeutic choices should be determined while taking into account not only changes for immediate improvement, but also both the risks for late-occurring complications and the following quality of life. We rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1a3b3f4eecea18b3d4e423871eeb914
https://doi.org/10.1182/blood.v76.11.2222.bloodjournal76112222
https://doi.org/10.1182/blood.v76.11.2222.bloodjournal76112222
Autor:
D Jan, F Z Ardjoun, Yann Revillon, Y Najean, R. Girot, M. de Montalembert, M Belhani, L Adjrad
Publikováno v:
Archives of Disease in Childhood. 65:304-307
Partial splenectomy was performed on 30 patients with homozygous beta thalassaemia to reduce blood requirements and to avoid the risk of overwhelming postsplenectomy infections; 24 patients had thalassaemia major and six thalassaemia intermedia. Five
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f3f83e666089c14231f1d6c1479cd9
https://doi.org/10.1136/adc.65.3.304
https://doi.org/10.1136/adc.65.3.304